Company intelligence / Profile preview

Leinco Technologies

St. Louis/Fenton, Missouri, United Statesleinco.com ↗

Ownership: Private
Development stage: Commercial

Overview

Leinco Technologies supplies antibodies and recombinant proteins used in early discovery life science research. Their products support academic and industry scientists in generating data for publication or further development. They do not have clinical trial results as they do not develop therapeutics themselves.

Therapeutic areas: OncologyPulmonologyEndocrinologyImmunologyHematologyCardiovascularNeurologyInfectious Diseases
Modalities: Monoclonal antibodyPolyclonal antibodyRecombinant proteinPeptidesELISA kit (as a product type)Small molecule (as part of assay reagents and detection kits)
Industry: Contract Manufacturing Organization

Partnerships

Not specifically disclosed; collaborates with academic researchers and biopharma clients via custom R&D/manufacturing services.

Beyond the preview

Go deeper on Leinco Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leinco Technologies.